AstraZeneca India opens new Mumbai office for next phase of growth through innovation

AstraZeneca Pharma India has inaugurated its new corporate office in Mumbai, marking an extension of company’s presence in India, reinforcing its ambition to transforming care by unlocking the power of science.

The new office spread across 25,600 sq ft was inaugurated Devendra Fadnavis, Chief Minister of Maharashtra alongside senior government officials, dignitaries from embassies and AstraZeneca team.

AstraZeneca has introduced more than 25 new medicines and indications in India over the past three years and is currently running about 80 global clinical trials in the country, supporting the development of new treatments, strengthening India’s contribution to global research and getting the right medicines to the right patients, faster.

Devendra Fadnavis, Chief Minister of Maharashtra, said “Maharashtra has a strong and growing pharmaceutical and life sciences ecosystem, supported by skilled talent, leading institutions and robust healthcare infrastructure. AstraZeneca’s decision to establish its India commercial office in Mumbai reflects confidence in the state’s capabilities and its potential as an innovation hub."

“India is at an important inflection point in healthcare, with a growing need for earlier diagnosis, innovative treatments and more equitable access,” said Praveen Rao Akkinepally, Country President and Managing Director, AstraZeneca Pharma India. “Our stronger presence in Mumbai strengthens our ability to work with partners across the healthcare ecosystem and advance solutions that address the needs of patients in India. Our strong workforce of nearly 5,000 colleagues across the country are united by a common ambition to follow the science, advance access to life saving therapies and help more people live better, healthier lives.”

This step will also support AstraZeneca’s continued investment in talent and capability building in India, creating opportunities for professionals who are passionate about transforming healthcare through science, technology and collaboration. As the company expands, it will seek to attract and develop diverse talent across the value chain.

Establishing a stronger footprint in Mumbai is a part of AstraZeneca’s broader purpose of advancing equitable healthcare globally.